ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,286.12
      -0.35%
      US Tech 100
      18,328.02
      0.05%
      Dow Jones
      38,741.84
      -0.84%
      Brent Oil
      84.11
      1.53%
      Bitcoin
      67,338.39
      -2.96%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Structure Therapeutics Inc (GPCR)

      7. Structure Therapeutics Inc (GPCR) News

      GPCR

      Structure Therapeutics (GPCR)

      Structure Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GPCR
      DateTimeSourceHeadlineSymbolCompany
      05/09/20244:56PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GPCRStructure Therapeutics Inc
      05/09/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
      05/09/20244:05PMGlobeNewswire Inc.Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
      03/08/20244:19PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:GPCRStructure Therapeutics Inc
      03/08/20244:05PMGlobeNewswire Inc.Structure Therapeutics to Present at Leerink Partners Global Biopharma ConferenceNASDAQ:GPCRStructure Therapeutics Inc
      03/08/20249:19AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GPCRStructure Therapeutics Inc
      03/08/20248:43AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
      03/08/20248:30AMGlobeNewswire Inc.Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
      12/18/20238:28AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
      12/18/20237:30AMGlobeNewswire Inc.Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical StudyNASDAQ:GPCRStructure Therapeutics Inc
      11/30/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GPCRStructure Therapeutics Inc
      11/17/20235:25PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:GPCRStructure Therapeutics Inc
      11/17/20234:55PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GPCRStructure Therapeutics Inc
      11/17/20234:51PMEdgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:GPCRStructure Therapeutics Inc
      11/16/20235:13PMEdgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:GPCRStructure Therapeutics Inc
      11/14/20234:10PMGlobeNewswire Inc.Structure Therapeutics Reports Third Quarter 2023 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
      09/29/20237:50AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
      09/29/20237:38AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
      09/29/20237:32AMGlobeNewswire Inc.Structure Therapeutics Announces $300 Million Private Placement Equity FinancingNASDAQ:GPCRStructure Therapeutics Inc
      09/29/20237:30AMGlobeNewswire Inc.Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program UpdateNASDAQ:GPCRStructure Therapeutics Inc
      08/10/20234:41PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GPCRStructure Therapeutics Inc
      08/10/20234:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
      08/10/20234:05PMGlobeNewswire Inc.Structure Therapeutics Reports Second Quarter 2023 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
      08/04/20234:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
      08/03/20235:32PMGlobeNewswire Inc.Structure Therapeutics Appoints Ted W. Love, M.D., to Board of DirectorsNASDAQ:GPCRStructure Therapeutics Inc
      07/06/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
      06/07/20238:30AMGlobeNewswire Inc.Structure Therapeutics Announces Poster Presentations of its Oral GLP-1 Receptor Agonist GSBR-1290 at the American Diabetes Association 83rd Scientific SessionsNASDAQ:GPCRStructure Therapeutics Inc
      06/05/20234:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GPCRStructure Therapeutics Inc
      05/31/20234:30PMGlobeNewswire Inc.Structure Therapeutics to Present at Jefferies Healthcare ConferenceNASDAQ:GPCRStructure Therapeutics Inc
      05/25/20234:30PMGlobeNewswire Inc.Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and ObesityNASDAQ:GPCRStructure Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:GPCR

      Your Recent History

      NYSE
      ALL-I
      Allstate
      BIT
      P1WPN6
      NLBNPIT1WPN6 20240621 31...
      Delayed Upgrade Clock